Related by context. All words. (Click for frequent words.) 68 WHI Dietary Modification 60 Periodontal Therapy 58 Prostate Cancer Prevention 57 Randomised 55 Haydock Champion Hurdle 55 totesport.com Derby 55 infamous Scopes Monkey 55 National Emphysema Treatment 55 multicenter randomized controlled 54 multicentre randomized controlled 54 Asymptomatic Carotid 54 Randomized controlled 53 Ovarian Cancer Screening 52 VESTASYNC 52 ACCORD Lipid 52 Tribble ations 51 NSABP B 51 #:#:# PMCategories Hans Reiser 51 Si Mi 51 EURIDIS 51 Multicenter Automatic Defibrillator Implantation 51 Long Lesion 51 Glucosamine Chondroitin Arthritis 50 Intervention Trial 50 Scandinavian Cardiac Outcomes 50 Prosecution Rests Case 50 Multicenter Randomized 50 Phase IIb III 50 Huggins Cams Time 49 cluster randomized controlled 49 Placebo controlled 49 BRIM3 49 Arimidex Tamoxifen Alone 49 Confirmatory 49 ONTARGET R 48 Brother Jero 48 Pre Exposure Prophylaxis 48 Phase Ib clinical 48 CAMMS# 48 PREVENT IV 48 Lung Cancer Screening 48 TAXUS ATLAS Small 48 Sibutramine Cardiovascular Outcomes 48 Active Ulcerative Colitis 48 Confirms Efficacy 47 RIO Lipids 47 Intervention Effectiveness 47 Pivotal Phase II 47 CLOTS 47 Phase IIIb clinical 47 Multicenter 47 Trials 47 RE MODEL 47 multicenter randomized clinical 47 Randomized placebo controlled 47 multicentre randomized 47 Phase III AFFIRM 47 Prostate AdenoCarcinoma Treatment 47 Mosquirix 47 Urgent Intervention Triage 47 Phase III Psoriasis 46 Intervention Effectiveness CATIE 46 fidaxomicin Phase 3 46 Pivotal Phase III 46 Randomized Evaluation 46 phase Ib clinical 46 Confirmatory Phase 46 Adjuvant Breast Cancer 46 BUB Motorcycle Speed 46 Meta analyzes 46 Initiate Phase II 46 CLARITY TIMI 46 ENDEAVOR IV clinical 46 Randomized Phase II 46 ToGA 46 Combination REOLYSIN R 45 Amoxicillin PULSYS Phase III 45 PROTECT AF 45 tribulations Groenveld 45 PLCO 45 RE LY ® 45 Eluting 45 Phase IIB 45 Phase Ib II 45 Expert Testifies 45 Placebo Controlled Trial 45 ERSPC 45 ABCSG 45 Lawrencia Bembenek Story 45 subanalysis 45 IIa Clinical Trial 45 TAXUS ATLAS 45 Phase IIA 45 Malaria Vaccine 45 intratumoural 45 Cloretazine ® 44 Trial 44 CURRENT OASIS 7 44 phase IIa clinical 44 Defense Rests Case 44 Raloxifene Evaluation MORE 44 Reduce Cardiovascular 44 AVADO 44 STOP AF 44 Polyp Prevention Trial 44 Dextofisopam Phase 2b 44 Systems IVRS Clinical 44 HCV RESPOND 2 44 Jury Deliberations Continue 44 Randomized Study 44 PFO migraine 44 ENESTnd 44 AVERROES 44 ENDEAVOR III 44 Inhibits Growth 44 WHIMS 44 Alpha Tocopherol Beta Carotene 44 Jury Deliberations Begin 44 fidaxomicin Phase 44 Pharmacokinetic PK 44 Raloxifene STAR 44 trials RCTs 44 Court Erred 44 Phase Ib IIa 43 PERSEUS 43 CARE HF 43 phase IIb III 43 randomized multicentre 43 specified primary endpoint 43 AIM HIGH 43 ORAL Sync 43 Oral Insulin Capsule 43 COR Diabetes 43 CAMMS# Phase 2 43 Phase III psoriasis 43 randomized Phase IIb 43 Initiate Phase 43 Phase 2a preventative 43 Network HPTN 43 randomized controlled clinical 43 Rotavirus Vaccine 43 Phase 2b Study 43 Phase 1a clinical 43 NCT# ClinicalTrials.gov 43 Randomized Double Blind 43 Phase IIB clinical 43 MADIT II 43 Protease Inhibitors 43 IMPACT IMmunotherapy 43 Pharmacodynamic 43 Closing Arguments Expected 43 Prostate Lung Colorectal 42 multicenter phase 42 Closing Arguments Heard 42 Val HeFT 42 Cholera Vaccine 42 acai pill 42 Universal Flu Vaccine 42 HCV SPRINT 42 registrational Phase 42 phase IIa 42 Initiate Phase III 42 dose escalation clinical 42 Sheep Dog 42 HIVNET 42 Trovax 42 DASISION 42 SCD HeFT 42 CUSTOM III 42 trials 42 ISEL 42 fosbretabulin 42 Jury Returns 42 Phase 1a 42 Refractory Angina 42 Clinical Antipsychotic Trials 42 Efficacy Trial 42 Oral Abstract 42 Cloretazine R 42 blinded randomized controlled 42 ACTIVE W 42 Rwanda Gacaca 42 Serological 42 DIABECELL R 42 Non Inferiority 42 Adjuvant Colon Cancer 42 Phase IIIb 42 Demonstrates Efficacy 42 Results Confirm 42 IMPACT DCM clinical 42 TB Vaccine 42 Phase 1b clinical 42 Subgroup analysis 42 Pooled Analysis 42 prospective multicentre 42 Microbicide 42 Pivotal Phase 42 EVA 3S 41 Histopathological 41 Randomized Double blind 41 Clinical Validation 41 Initiates Phase III 41 Phase #/#a clinical 41 ongoing Phase 1b 41 VIR# 41 multicenter randomized placebo controlled 41 UPLYSO 41 riociguat 41 Attorney Jonathan Skrmetti 41 PENNVAX B 41 Trial NLST 41 multicentre 41 Multiple Ascending Dose 41 CHAMPION PCI 41 pivotal bioequivalence 41 randomized multicenter trial 41 Integra Shocks Time 41 SORT OUT III 41 VADT 41 phase IIb clinical 41 Phase III registrational 41 SPIRIT FIRST 41 phase IIIb 41 Phase III VISTA 41 landmark ATHENA 41 myopic CNV 41 ENGAGE AF TIMI 41 Phase III Clinical Trial 41 Delcath Phase III 41 doxorubicin docetaxel 41 recurrent malignant glioma 41 Anthrax Vaccine 41 randomized multicenter Phase III 41 SIMPADICO 41 SPIRIT III 41 Sorafenib HCC Assessment 41 Phase #b/#a clinical 41 TMC# C# 41 Phase III Trial 41 ONTARGET 41 Jury Deadlocks 41 CVBT #H 41 CBLC# 40 Oral Fingolimod 40 Bioequivalence 40 ALSYMPCA 40 Diamyd Medical Diamyd 40 trastuzumab DM1 40 multicenter clinical 40 Prolongs Survival 40 Trial Issue www.emagazine.com 40 Adjuvant Treatment 40 http:/www.investorsobserver.com/freemo2 40 trastuzumab DM1 T DM1 40 BETAS 40 LUMINATE 40 Anticancer Drug 40 Opening Arguments Begin 40 Udatalawinna massacre 40 Immunohistochemical 40 Witnesses Testify 40 Initiated Phase 40 Diana Inquest 40 Conclusive 40 activating EGFR mutations 40 cellulose sulfate 40 Jury Selection Resumes 40 TASKi2 40 TG MV 40 PreCISe 40 Teva Provides Update 40 Metallurgical testwork 40 Treason Trial 40 MEND CABG 40 randomized Phase III 40 designated HVTN 40 Pivotal Trials 40 TRANSFORMS 40 RECORD1 40 Initiates Phase 2b 40 subgroup analyzes 40 Abu Ghraib Abuse 40 EXPLORE Xa 40 RE LY 40 olaparib 40 Preliminary Metallurgical 40 badger culls 40 BRIM2 40 Pharmacokinetic 40 Long Term Outcomes 40 STEALTH C 40 multicenter prospective 40 DSMB recommended 40 Results Indicate 40 Combination Treatment 40 Histological 40 Pivotal Trial 40 Yates Retrial 40 multicenter Phase II 40 Trial Initiative LSTI 40 RCTs 40 DAPT 40 blind randomized controlled 39 prospective randomized placebo 39 Clinical Trial Results 39 randomized controlled multicenter 39 Phase 2b kidney transplant 39 Toxicological 39 cellulose sulphate 39 double blinded randomized 39 ONCONASE R 39 Quantitative Impact 39 MERIT ES 39 randomized controlled Phase 39 DIABECELL ® 39 Cholesterol Levels SPARCL 39 NO# [002] 39 Deliberations Continue 39 CUSTOM II 39 Motesanib 39 Histologic 39 prospective multicenter 39 Maximum Tolerated Dose MTD 39 iPrEx 39 Drug Fails 39 Molecular Mechanism 39 florbetaben 39 preclinical pharmacokinetic 39 identifier NCT# 39 Postmortem 39 Vaccine Trial 39 rhLF 39 Safinamide 39 Randomized Clinical Trial 39 HDAC Inhibitor 39 Lung Cancer Drug 39 randomized blinded 39 phase IIb 39 Protein Synthesis 39 Land Rover Burghley Horse 39 ENDEAVOR II 39 Retesting 39 CALGB # [002] 39 Trial Evaluating 39 GM herbicide tolerant 39 REMEDIAL II 39 evaluating satraplatin plus 39 Phil Spector Murder Trial 39 IIa clinical 39 Phase 2b monotherapy 39 AVN# Phase 39 nonrandomized 39 Heap leach 39 COSTAR II 39 MADIT 39 PCI ExTRACT TIMI 39 assessing T DM1 39 Prostate Cancer Vaccine 39 Multi MERCI 39 multicenter randomized 39 Feasibility 39 Dendreon Provenge 39 Pharmacokinetic Study 39 randomized blinded placebo 39 Controlled Study 38 Phase #b/#a 38 IMPACT DCM 38 FDG-PET/CT 38 eliglustat tartrate 38 Shows Efficacy 38 CATIE AD 38 CHAMPION PLATFORM 38 Lm vaccine 38 VaxGen AIDSVAX 38 Jury Retires 38 Microarray analysis 38 AP IMPACT Credibility 38 Inflammatory Arthritis 38 Certej Project 38 Bacteriological 38 ADVANCE PD 38 Tribulations 38 multicentre prospective 38 randomized controlled trials RCTs 38 placebo controlled randomized 38 TASKi3 38 tolevamer 38 Seasonal Flu Vaccine 38 BioSante Pharmaceuticals Reports 38 Phase III Pivotal Trial 38 Xelox 38 confirmatory clinical 38 Cervical Cancer Vaccine 38 canakinumab 38 Jurors Deliberate 38 parasitological 38 preclinical efficacy 38 Pre RELAX AHF 38 Pandemic Influenza Vaccine 38 Jury Hears Closing Arguments 38 Nears Conclusion 38 GSMA IPX 38 refractory prostate cancer 38 Neuvenge 38 ADONIS 38 Cinquil 38 ENDEAVOR IV 38 prospective randomized controlled 38 Lung Cancer Trial 38 vaginal microbicide 38 SPIRIT IV 38 placebo controlled clinical 38 Voir Dire 38 offshore penal colonies 38 Phase Ia 38 Clinical Outcomes Utilizing Revascularization 38 Improves Survival 38 ICON7 38 EINSTEIN DVT 38 trastuzumab emtansine T DM1 38 Mitsubishi Motors Badminton Horse 38 Phase Ib 38 Drug Candidate 38 Anticancer Compound 38 Edge STudy 38 Uncertainty Surrounds 38 randomized Phase 2b 38 ADAGIO study 38 Reanalysis 38 Phase III Clinical Trials 38 Phase IIb kidney transplant 38 Phase III randomized controlled 38 AOD# [002] 38 prospective randomized multicenter 38 LabCorp conducts clinical 38 Rests Case 38 Myocardial Infarction Study 38 Patients Treated With 38 Onconase 38 Woman Testifies 38 Eradicates 38 Testimony Ends 37 Serious Adverse Event 37 hepatitis B vaccine Heplisav 37 PROactive study 37 Agress TM 37 Medidur TM FA 37 Testimony Continues 37 Multimeric 37 Deliberations Begin 37 RE SURGE 37 AMMTEC 37 DiabeCell R 37 Jury Mulls 37 phase III ACCLAIM 37 Dose Ranging Study 37 Testimony Begins 37 Vaccine Prevents 37 EndoTAG TM -1 37 NVA# 37 Metallurgical Testwork 37 HPTN 37 silver medalist Emma Pooley 37 multicenter placebo controlled 37 randomized crossover 37 HF ACTION 37 Jury Selection Continues 37 intravenous dosing 37 phase Ib 37 treatment naive genotype 37 Deliberations Resume 37 blinded randomized 37 Anticancer Activity 37 Corlux 37 SUTENT ® 37 prospective observational studies 37 Closing Arguments Begin 37 Placebo Controlled 37 PSMA ADC 37 Key Witness Testifies 37 GENASIS clinical 37 placebo controlled multicenter 37 OLYMPIA registry 37 Daughter Testifies 37 APEX PD 37 SAR# [004] 37 recurrent metastatic 37 investigational protease inhibitor 37 reactogenicity 37 Phase IIb dose 37 Keflezighi hobbled 37 GSM1x 37 PRIMO CABG 37 pharmacokinetic PK study 37 SYMMETRY trial 37 combination REOLYSIN 37 double blinded placebo 37 Histopathologic 37 ANCHOR trial 37 Exhaustive 37 ACCEDE 37 BNC# 37 optimal dosing 37 Stem Cell Treatment 37 EMPHASIS HF trial 37 masked placebo controlled 37 dose escalation Phase 37 Phase II 36 ancrod 36 Gene Therapy Advisory 36 O2 Wallet 36 multicenter multinational 36 PD2i CA 36 Jury Seated 36 MS spasticity 36 Reolysin 36 Trial Halted 36 Case Postponed 36 Ushercell 36 Orazol 36 Phase 2b Clinical Trial 36 Edwards SAPIEN valve 36 ConclusionThis 36 MIST II 36 Van Occupanther 36 novel VDA molecule 36 RTS S/AS# 36 REOLYSIN ® 36 dose escalation phase 36 GRNVAC1 36 Vaxfectin R formulated 36 Progression TTP 36 Erectile Dysfunction Drug 36 Scopus Affiliation Identifier 36 Phase Ib IIa clinical 36 IND Application 36 Vectibix panitumumab 36 Alan Tieger 36 PROSTVAC TM 36 multicenter trials 36 Hormone Refractory Prostate Cancer 36 OncoVex 36 Jaw Bone 36 unblinding 36 PANVAC VF 36 Data Indicate 36 observational studies 36 Defendant Testifies 36 phase 2a 36 confirmatory 36 Dr. Jeffrey Probstfield 36 Prefeasibility 36 MelaFind pivotal 36 CLARITY study 36 AERAS-#/Crucell Ad# 36 Thorough QT 36 Murder Convictions 36 OBPM 36 evaluating mipomersen 36 Coronary CTA 36 Recurrent Prostate Cancer 36 downhole gamma logging 36 NDA Submission 36 CT Colonography Trial 36 AKC Agility 36 First Patient Dosed 36 ASCO Abstract 36 grindability 36 TheraCIM h R3 36 ABSORB clinical 36 Mimetic 36 Waives Right 35 Antiarrhythmic 35 Feasibility studies 35 ACV1 35 Elocalcitol 35 Findings 35 II Clinical Trial 35 CALGB 35 Tolamba 35 RPL# 35 Phase III placebo controlled 35 adjuvant colon cancer 35 Observational studies 35 Jury Begins Deliberations 35 BLOOM DM 35 randomized clinical 35 isavuconazole 35 Estimations 35 COMFORT II 35 CCR5 inhibitor 35 WSB Qualifying 35 GRAVITAS trial 35 Interferon Alpha 35 Phase 2b dose 35 Artery Disease 35 Improves Outcomes 35 clinicaltrials.gov 35 Lethality 35 Proves Effective 35 R# #mg BID 35 Testwork 35 crizotinib PF # 35 Witness Testifies 35 Final 35 rougher flotation 35 placebo controlled Phase III 35 Medidata Designer 35 Primary endpoints 35 Trial Hears 35 REMUNE R 35 HOPE TOO 35 Folfox 35 Geochemical Survey 35 CEQ# 35 Necropsy 35 Doping Case 35 Kindergarten Futurity 35 Opening Arguments 35 histopathological 35 OncoVEX GM CSF 35 abiraterone 35 VNP#M 35 Patient Enrolment 35 tesmilifene Phase III 35 randomized controlled clinical trials 35 UKPDS 35 XL# SAR# 35 Multikine ® 35 Prosecution Rests 35 microbicide trials 35 Ditech Networks VQA 35 viral kinetic 35 Epidemiologic studies 35 Appeal Dismissed 35 Orientated 35 CLIRS 35 LC#m# 35 FlutiformTM 35 Lovaxin C 35 DXL# 35 Closing Arguments Set 35 Daniel Fransen 35 Trial Adjourned 35 Arguments Begin 35 Preliminary metallurgical 35 Environment Impact Statement 35 Cholesterol Drug 35 iPrEx study 35 Increased Incidence 35 histologic findings 35 thorough QT 35 TransMID 35 BIOX R 35 Brain Scans 35 rotary VAD 35 TBC M4 35 preclinical pharmacology 35 phase IIb study 35 relapsing remitting MS RRMS 35 rBChE 35 Reduced Incidence 35 Epidemiological 35 TRIALS 35 galiximab 35 Artificial Liver 35 Followup 35 '# '# '# 35 confirmatory Phase 35 Aidsvax 35 randomized multicenter 35 GeoVax vaccine 35 EchoCRT 34 Dose escalation 34 Jury Tampering 34 Juror Dismissed 34 TransVax ™ 34 Individualized Treatment 34 Jury Selection Underway 34 rPA anthrax vaccine 34 Shows Promise Against 34 TEC #OL 34 neurologic progression 34 tesofensine 34 Therapy Shows Promise 34 SCENESSE ® 34 Jurors Deliberating 34 Phase IIa clinical 34 acyclovir Lauriad R 34 Phase IIb Clinical Trial 34 Univariate 34 Valve Replacement 34 mean ± SEM 34 Subgroup analyzes 34 Alequel 34 Albuferon Phase 34 GLP toxicology studies 34 dosing cohorts 34 Verdict Expected 34 Phase III randomized 34 Viveta 34 lowering triglyceride levels 34 APEX AMI 34 toxicological studies 34 Effectively Treats 34 Ereska 34 Spector Murder Trial 34 Phase 1b Clinical Trial 34 Phase IIIb study 34 PRIMO CABG2 34 Lung Cancer Vaccine 34 ORBIT II 34 ground radiometric surveying 34 Vaccine Trials 34 rALLy 34 tramiprosate Alzhemed TM 34 1Mtpa 34 subcutaneous PRO 34 meta analysis pooling 34 Preliminary 34 Onalta ™ 34 Rape Trial 34 Burkina Faso Gabon 34 prospective observational 34 initiate Phase 2b 34 Exherin TM 34 Preclinical Evaluation 34 placebo controlled Phase 34 voire dire 34 NSABP 34 Genome Diagnostics 34 nonjury civil 34 Bulk sampling 34 Phase #/#a 34 multicentre randomized double 34 TM Drug Eluting 34 Match Fixtures 34 Gradient Array 34 TriGrid 34 Microdiamond 34 modified REGENESIS Phase IIb 34 Drug Shows Promise 34 arzoxifene 34 Post mortem examination 34 Teen Sniper Suspect 34 Testimony Resumes 34 Request Denied 34 Death Sentences 34 RIO Diabetes 34 Quantitative RT PCR 34 Results 34 Phase 34 Phase III TRIST 34 virologic responses 34 resminostat 34 oral rivaroxaban 34 Severn Tidal Power 34 Vacuum Assisted 34 candidates Dyloject TM 34 labial herpes 34 initiate Phase Ib 34 Trastuzumab DM1 34 AE# vaccine 34 Ruidoso Futurity 34 trial 34 flowsheet 34 trialing 34 Post hoc 34 Retrials 34 Newmont Exec 34 EGS# 34 Rape Conviction 34 MAGE A3 ASCI 34 Gag Order Issued 34 canagliflozin 34 ENRICH trial 34 TQ Micro 34 heap leach amenability 34 demonstrated antitumor activity 34 Enters Beta 34 LUVENIQ 34 Diabetic Ulcers 34 Trial Nears 34 Optimised Feasibility Study 34 GeoVax HIV AIDS 34 alvespimycin 34 Implicates 34 Unpublished 34 TAXUS IV 34 Pivotal Clinical Trial 34 randomized trials 34 pertuzumab 34 Waraga 1 34 biochemical assays 34 Para Cycling 33 mapatumumab 33 Hannukainen 33 GSK# [002] 33 denosumab oncology 33 mg/m2 cohort 33 evaluating Prochymal 33 Acquit 33 TAXUS VI 33 www.ingenuity.com 33 Speed Humps 33 Pagoclone 33 Cloretazine R VNP#M 33 Preliminary Results 33 Diplock courts 33 EmbraceAC 33 CLL8 33 REALITY Trial 33 HVTN 33 IIb clinical trial 33 Tanespimycin 33 Phase III ALLEGRO 33 Case Adjourned 33 Witness Describes 33 SUCCEED trial 33 number NCT# ClinicalTrials.gov 33 Phase III 33 Double Blind Placebo 33 telaprevir dosing 33 OMP #M# 33 Evidences 33 ACOSOG Z# 33 Ultrafast Insulin 33 masitinib 33 Feasibility Studies 33 Kangaluwi 33 tanespimycin 33 Novo TTF 33 GetGoal Phase III 33 OvaRex 33 Multivariate analysis 33 Phase Ib Clinical Trial 33 Sensitivity analyzes 33 jury nobbling 33 Diamyd r vaccine 33 Awaits Fate 33 Tocosol 33 Clinical Trial Enrollment 33 TAXUS V 33 ORMD 33 Retests 33 HORIZONS AMI trial 33 2D Seismic 33 Completes Enrollment 33 Acceptance Testing 33 Phase III Trials 33 floatation circuit 33 GVAX 33 IIa trials 33 Momenta Pharmaceuticals Announces 33 Neo Bladder Augment 33 demonstrated clinically meaningful 33 Proves Successful 33 anastrazole 33 Upward Revision 33 Sodomy II 33 Hearing Begins 33 Summations 33 Techni lab 33 budesonide foam 33 randomized controlled trials 33 Cross Examined 33 microwaved baby 33 initiate Phase 1b 33 Tests Reveal 33 MADIT CRT 33 multicenter Phase 33 mg administered orally 33 TACI Ig 33 ganaxolone 33 Clinical Trial Evaluating 33 RhuDex 33 pharmacokinetic studies 33 DEB# 33 Accused Cop Killer 33 Chronic Inflammation 33 Airborne Geophysical 33 Prioritized 33 Committee IDMC 33 Guilty Verdicts 33 Carraguard 33 Ruled Incompetent 33 MADIT CRT trial 33 challenger Mohsen Rezaei 33 Jury Deadlocked 33 MIRCERA 33 Cangrelor 33 Neonatal Diabetes 33 rALLy trial 33 Delayed 33 Alfimeprase 33 Nordic ACTI 33 Jury Deliberations 33 Ragweed Allergy 33 Randomized Trials 33 pharmacokinetic characteristics 33 ThermoDox ® clinical 33 TLR9 mediated immune 33 methodologically rigorous 33 AMPAKINE CX# 33 vitro experiments 33 BST CarGel R 33 epothilone KOS 33 ralfinamide 33 Possible Motive 33 Sentencing Hearing 33 AERAS 33 Inquest Into 33 Heplisav 33 Princess Diana Inquest 33 breast cancer recurrences 33 retapamulin 33 Court Overturns Ruling 33 Schiavo Autopsy 33 oral deforolimus 33 Ex Convict 33 Issues Gag Order 33 Arthritis Drug 33 Jury Picked 32 Phase 2b 32 Cites Positive 32 Preliminary Feasibility 32 neratinib 32 PSN# [002] 32 Resentencing 32 Opportunity Assessment 32 #th Annual Interscience 32 Inquiry Finds 32 paroxetine Seroxat 32 Phase IIIa 32 Jurors Hear 32 Hyphanox 32 BTK Suspect 32 Mother Testifies 32 Prostate Cancer Treatment 32 Documents Detail 32 Novartis Zometa 32 Urocidin 32 ataluren 32 Trial Continues 32 paclitaxel poliglumex 32 Water Rationing 32 Marillana 32 vitro dissolution 32 Clinical Trial 32 YONDELIS 32 Jury Recommends 32 Awaits Verdict 32 champion Anna Meares 32 Greystar Resources Announces 32 blinded placebo controlled 32 Caged Kids 32 Ophena 32 Fast Reactor 32 elacytarabine 32 candidate CRLX# 32 Rape Claim 32 Toni Bou 32 CCR5 antagonist 32 Geochimica et Cosmochimica Acta 32 Rejects Request 32 clinical pharmacology studies 32 Fraud Conviction 32 formal pharmacokinetic PK 32 Judge Denies Bail 32 Telintra 32 TRIAL 32 Adis Medunjanin awaits 32 Convictions Upheld 32 inecalcitol 32 Death Penalty Case 32 RSD# oral 32 Operational Clearance 32 Pendalian 32 IIa trial 32 Tykerb lapatinib 32 Phase IIIB IV 32 Prodarsan 32 Production Capacities 32 Permit Approval 32 CytoFabTM 32 olanzapine LAI 32 Malpractice Suit 32 Bribery Trial 32 Fort Dix Plot 32 Guantanamo Detainees 32 docetaxel Taxotere ® 32 Study ADCS 32 Phase IIb trials 32 Life Imprisonment 32 Advagraf 32 User Acceptance 32 Guantanamo Detainee 32 Sniper Trial 32 Jointing